{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:11:33Z","timestamp":1783555893538,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["MIS 5047829"],"award-info":[{"award-number":["MIS 5047829"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["50\/28.05.2020"],"award-info":[{"award-number":["50\/28.05.2020"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jchromb.2022.123229","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T20:34:28Z","timestamp":1647635668000},"page":"123229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Accumulation of zoledronic acid in rabbit intervertebral discs"],"prefix":"10.1016","volume":"1197","author":[{"given":"Christophoros","family":"Christophoridis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Kouroumalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Kletsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2022.123229_b0005","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jchromb.2022.123229_b0010","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/00007632-200002150-00016","article-title":"Low back pain in relation to lumbar disc degeneration","volume":"25","author":"Luoma","year":"2000","journal-title":"Spine"},{"key":"10.1016\/j.jchromb.2022.123229_b0015","doi-asserted-by":"crossref","unstructured":"N. Boos, S. Weissbach, H. Rohrbach, C. Weiler, K.F. Spratt, A.G. Nerlich, Classification of age-related changes in lumbar intervertebral discs: 2002 Volvo Award in basic science, Spine, 27 (2002) 2631-2644.","DOI":"10.1097\/00007632-200212010-00002"},{"key":"10.1016\/j.jchromb.2022.123229_b0020","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/00007632-199005000-00011","article-title":"Investigation of the laminate structure of lumbar disc anulus fibrosus","volume":"15","author":"Marchand","year":"1990","journal-title":"Spine"},{"key":"10.1016\/j.jchromb.2022.123229_b0025","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/00007632-199503150-00008","article-title":"The large proteoglycans of the human intervertebral disc. Changes in their biosynthesis and structure with age, topography, and pathology","volume":"20","author":"Johnstone","year":"1995","journal-title":"Spine"},{"key":"10.1016\/j.jchromb.2022.123229_b0030","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/ar629","article-title":"Degeneration of the intervertebral disc","volume":"5","author":"Urban","year":"2003","journal-title":"ArthritisRes. Therapy"},{"issue":"S3","key":"10.1016\/j.jchromb.2022.123229_b0035","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s00586-006-0126-8","article-title":"Senescence in human intervertebral discs","volume":"15","author":"Roberts","year":"2006","journal-title":"European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society"},{"key":"10.1016\/j.jchromb.2022.123229_b0040","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00003086-197711000-00012","article-title":"Nutrition of the intervertebral disk. An in vivo study of solute transport","author":"Urban","year":"1977","journal-title":"Clinical Orthopaedics Related Res., DOI"},{"issue":"8","key":"10.1016\/j.jchromb.2022.123229_b0045","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00586-003-0616-x","article-title":"Effect of nutrient deprivation on the viability of intervertebral disc cells","volume":"13","author":"Bibby","year":"2004","journal-title":"European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society"},{"issue":"6","key":"10.1016\/j.jchromb.2022.123229_b0050","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1297-319X(01)00332-3","article-title":"The pathophysiology of the intervertebral disc","volume":"68","author":"Bibby","year":"2001","journal-title":"Joint, bone, spine : revue du rhumatisme"},{"key":"10.1016\/j.jchromb.2022.123229_b0055","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.spinee.2012.03.035","article-title":"The effect of therapies for osteoporosis on spine fusion: a systematic review","volume":"13","author":"Hirsch","year":"2013","journal-title":"The spine J.: official J. North American Spine Society"},{"key":"10.1016\/j.jchromb.2022.123229_b0060","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s00586-019-06090-2","article-title":"Radiographic and functional outcomes of bisphosphonate use in lumbar fusion: a systematic review and meta-analysis of comparative studies","volume":"29","author":"Fretes","year":"2020","journal-title":"European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society"},{"key":"10.1016\/j.jchromb.2022.123229_b0065","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2165\/00003495-199142060-00003","article-title":"Bisphosphonates Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease","volume":"42","author":"Fleisch","year":"1991","journal-title":"Drugs"},{"key":"10.1016\/j.jchromb.2022.123229_b0070","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s11914-018-0430-3","article-title":"Recent Advances in Understanding Bisphosphonate Effects on Bone Mechanical Properties","volume":"16","author":"Allen","year":"2018","journal-title":"Current osteoporosis reports"},{"key":"10.1016\/j.jchromb.2022.123229_b0075","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/8756-3282(95)00445-9","article-title":"Bisphosphonates: a review of their pharmacokinetic properties","volume":"18","author":"Lin","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.jchromb.2022.123229_b0080","doi-asserted-by":"crossref","first-page":"32","DOI":"10.14219\/jada.archive.2008.0017","volume":"139","author":"Grbic","year":"2008","journal-title":"J. Am. Dent. Assoc."},{"issue":"4","key":"10.1016\/j.jchromb.2022.123229_b0085","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4055\/cios.2013.5.4.292","article-title":"The effect of zoledronic acid on the volume of the fusion-mass in lumbar spinal fusion","volume":"5","author":"Park","year":"2013","journal-title":"Clinics in orthopedic surgery"},{"issue":"4","key":"10.1016\/j.jchromb.2022.123229_b0090","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.bone.2012.07.004","article-title":"Early effects of zoledronic acid and teriparatide on bone microarchitecture, remodeling and collagen crosslinks: comparison between iliac crest and lumbar vertebra in ewes","volume":"51","author":"Portero-Muzy","year":"2012","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.jchromb.2022.123229_b0095","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.joca.2010.06.007","article-title":"Inhibition of osteoclasts prevents cartilage loss and pain in a rat model of degenerative joint disease","volume":"18","author":"Strassle","year":"2010","journal-title":"Osteoarthritis and cartilage"},{"issue":"12","key":"10.1016\/j.jchromb.2022.123229_b0100","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/jor.22712","article-title":"Chondroprotective effect of high-dose zoledronic acid: An experimental study in a rabbit model of osteoarthritis","volume":"32","author":"Lampropoulou-Adamidou","year":"2014","journal-title":"J. Orthopaedic Research : Official Publication Orthopaedic Research Society"},{"issue":"8","key":"10.1016\/j.jchromb.2022.123229_b0105","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/jor.23442","article-title":"PTH(1\u201334) and zoledronic acid have differing longitudinal effects on juvenile mouse femur strength and morphology","volume":"35","author":"Bartlow","year":"2017","journal-title":"J. Orthopaedic Res. : Official Publication Orthopaedic Research Society"},{"key":"10.1016\/j.jchromb.2022.123229_b0110","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1053\/joca.2001.0506","article-title":"The effect of bone remodeling inhibition by zoledronic acid in an animal model of cartilage matrix damage","volume":"10","author":"Muehleman","year":"2002","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.jchromb.2022.123229_b0115","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1177\/009127002762491316","article-title":"Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases","volume":"42","author":"Chen","year":"2002","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2022.123229_b0120","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/0091270002239824","article-title":"The pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with varying degrees of renal function","volume":"43","author":"Skerjanec","year":"2003","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2022.123229_b0125","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.apradiso.2009.04.009","article-title":"The rabbit biodistribution of a therapeutic dose of zoledronic acid labeled with Tc-99m","volume":"67","author":"Asikoglu","year":"2009","journal-title":"Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine"},{"issue":"10","key":"10.1016\/j.jchromb.2022.123229_b0130","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1002\/jor.21394","article-title":"Chondroprotective effect of alendronate in a rabbit model of osteoarthritis","volume":"29","author":"Shirai","year":"2011","journal-title":"J. Orthopaedic Res. : Official Publication Orthopaedic Research Society"},{"key":"10.1016\/j.jchromb.2022.123229_b0135","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2460\/ajvr.75.4.329","article-title":"Chondroprotective effects of zoledronic acid on articular cartilage in dogs with experimentally induced osteoarthritis","volume":"75","author":"Dearmin","year":"2014","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.jchromb.2022.123229_b0140","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jchromb.2011.11.031","article-title":"Development and validation of a sensitive solid-phase-extraction (SPE) method using high-performance liquid chromatography\/tandem mass spectrometry (LC\u2013MS\/MS) for determination of risedronate concentrations in human plasma","volume":"881\u2013882","author":"Ghassabian","year":"2012","journal-title":"J. Chromatogr. B"},{"issue":"22","key":"10.1016\/j.jchromb.2022.123229_b0145","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.jchromb.2011.05.037","article-title":"Determination of zoledronic acid in human urine and blood plasma using liquid chromatography\/electrospray mass spectrometry","volume":"879","author":"Veldboer","year":"2011","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2022.123229_b0150","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/0731-7085(95)01572-8","article-title":"High-performance ion-exchange chromatography with in-line complexation of bisphosphonates and their quality control in pharmaceutical preparations","volume":"13","author":"Sparidans","year":"1995","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2022.123229_b0155","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1365\/s10337-004-0384-8","article-title":"Analysis of Zoledronic Acid and Its Related Substances by Ion-Pair RP-LC","volume":"60","author":"Jiang","year":"2004","journal-title":"Chromatographia"},{"key":"10.1016\/j.jchromb.2022.123229_b0160","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.aca.2006.11.012","article-title":"Development and validation of a reversed-phase ion-pair high-performance liquid chromatographic method for the determination of risedronate in pharmaceutical preparations","volume":"584","author":"Kyriakides","year":"2007","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jchromb.2022.123229_b0165","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.chroma.2008.12.051","article-title":"A sensitive post-column photochemical derivatization\/fluorimetric detection system for HPLC determination of bisphosphonates","volume":"1216","author":"P\u00e9rez-Ruiz","year":"2009","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2022.123229_b0170","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jpba.2005.03.020","article-title":"Analytical methods for the quantification of ibandronate in body fluids and bone","volume":"39","author":"Endele","year":"2005","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2022.123229_b0175","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1002\/rcm.2755","article-title":"A general approach for the quantitative analysis of bisphosphonates in human serum and urine by high-performance liquid chromatography\/tandem mass spectrometry","volume":"20","author":"Zhu","year":"2006","journal-title":"Rapid communications in mass spectrometry : RCM"},{"key":"10.1016\/j.jchromb.2022.123229_b0180","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jpba.2008.05.028","article-title":"Determination of bisphosphonate active pharmaceutical ingredients in pharmaceuticals and biological material: A review of analytical methods","volume":"48","author":"Zacharis","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2022.123229_b0185","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jchromb.2013.07.019","article-title":"Quantitation of zoledronic acid in murine bone by liquid chromatography coupled with tandem mass spectrometry","volume":"935","author":"Raccor","year":"2013","journal-title":"J. Chromatography B, Analytical Technol. Biomedical Life Sci."},{"key":"10.1016\/j.jchromb.2022.123229_b0190","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jpba.2018.09.042","article-title":"Development and validation of a method using ultra performance liquid chromatography coupled to tandem mass spectrometry for determination of zoledronic acid concentration in human bone","volume":"162","author":"Lo Faro","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2022.123229_b0195","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/aps.2012.28","article-title":"Efficacy of zoledronic acid in treatment of teoarthritis is dependent on the disease progression stage in rat medial meniscal tear model","volume":"33","author":"Yu","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jchromb.2022.123229_b0200","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s13075-018-1625-9","article-title":"Short Link N promotes disc repair in a rabbit model of disc degeneration","volume":"20","author":"Mwale","year":"2018","journal-title":"Arthritis research & therapy"},{"key":"10.1016\/j.jchromb.2022.123229_b0205","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1007-4376(08)60086-6","article-title":"An animal model to create intervertebral disc degeneration characterized by radiography and molecular biology","volume":"22","author":"Sun","year":"2008","journal-title":"J. Nanjing Med. Univ."},{"key":"10.1016\/j.jchromb.2022.123229_b0210","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/427138","article-title":"Organotypic Cultures of Intervertebral Disc Cells: Responses to Growth Factors and Signaling Pathways Involved","volume":"2015","author":"Pratsinis","year":"2015","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.jchromb.2022.123229_b0215","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0013-9351(87)80024-5","article-title":"In vitro cytotoxicity of organic pollutants to bluegill sunfish (BF-2) cells","volume":"42","author":"Babich","year":"1987","journal-title":"Environ. Res."},{"key":"10.1016\/j.jchromb.2022.123229_b0220","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0378-4274(85)90046-3","article-title":"Toxicity determined in vitro by morphological alterations and neutral red absorption","volume":"24","author":"Borenfreund","year":"1985","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.jchromb.2022.123229_b0225","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.tiv.2012.12.004","article-title":"Assessment of an automated in vitro basal cytotoxicity test system based on metabolically-competent cells","volume":"27","author":"Rodrigues","year":"2013","journal-title":"Toxicology in vitro : an International J. Published Association BIBRA"},{"issue":"7","key":"10.1016\/j.jchromb.2022.123229_b0230","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/nprot.2008.75","article-title":"Neutral red uptake assay for the estimation of cell viability\/cytotoxicity","volume":"3","author":"Repetto","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jchromb.2022.123229_b0235","doi-asserted-by":"crossref","unstructured":"A. Dimozi, E. Mavrogonatou, A. Sklirou, D. Kletsas, Oxidative stress inhibits the proliferation, induces premature senescence and promotes a catabolic phenotype in human nucleus pulposus intervertebral disc cells, European cells & materials, 30 (2015) 89-102; discussion 103.","DOI":"10.22203\/eCM.v030a07"},{"key":"10.1016\/j.jchromb.2022.123229_b0240","unstructured":"2002\/657\/EC, Commission Decision of 12 August 2002 implementing Council Directive 96\/23\/EC concerning the performance of analytical methods and the interpretation of results (Text with EEA relevance) (notified under document number C(2002) 3044) in: L 221, Official Journal of the European Communities, Brussels."},{"issue":"12","key":"10.1016\/j.jchromb.2022.123229_b0245","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0731-7085(96)02021-3","article-title":"An enzyme inhibition assay for the quantitative determination of the new bisphosphonate zoledronate in plasma","volume":"15","author":"Risser","year":"1997","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"6","key":"10.1016\/j.jchromb.2022.123229_b0250","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1590\/0103-6440201302229","article-title":"Cytotoxic effects of zoledronic acid on human epithelial cells and gingival fibroblasts","volume":"24","author":"Basso","year":"2013","journal-title":"Brazilian Dental J."},{"key":"10.1016\/j.jchromb.2022.123229_b0255","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1365-2141.2008.07504.x","article-title":"Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis","volume":"144","author":"Scheper","year":"2009","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.jchromb.2022.123229_b0260","first-page":"713","volume":"41","author":"Patntirapong","year":"2012","journal-title":"Pathology"},{"key":"10.1016\/j.jchromb.2022.123229_b0265","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.lfs.2018.04.059","article-title":"Zoledronic acid induces micronuclei formation, mitochondrial-mediated apoptosis and cytostasis in kidney cells","volume":"203","author":"Singireesu","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.jchromb.2022.123229_b0270","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3892\/mmr.2015.4627","article-title":"Dose-dependent inhibitory effects of zoledronic acid on osteoblast viability and function in vitro","volume":"13","author":"Huang","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jchromb.2022.123229_b0275","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejphar.2008.10.043","article-title":"Zoledronate inhibits the proliferation, adhesion and migration of vascular smooth muscle cells","volume":"602","author":"Wu","year":"2009","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.jchromb.2022.123229_b0280","doi-asserted-by":"crossref","first-page":"249","DOI":"10.11005\/jbm.2014.21.4.249","article-title":"Effect of zoledronate on the expression of vascular endothelial growth factor-a by articular chondrocytes and synovial cells: an in vitro study","volume":"21","author":"Yi","year":"2014","journal-title":"J. Bone Metabolism"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023222001337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023222001337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:19:00Z","timestamp":1778822340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023222001337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":56,"alternative-id":["S1570023222001337"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2022.123229","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Accumulation of zoledronic acid in rabbit intervertebral discs","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2022.123229","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"123229"}}